Alnylam Pharmaceuticals, Inc.

Erste Asset Management GmbH ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

26,010

Value ($000)

10,373

Weight

0.1%

2018 Q4 - 2025 Q4 (29 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	10,373	0.1%	26,010	12/31/2025
2025 Q3	11/12/2025	11,639	0.1%	26,010	9/30/2025
2025 Q2	8/14/2025	9,624	0.1%	29,810	6/30/2025
2025 Q1	5/14/2025	6,258	0.1%	23,310	3/31/2025
2024 Q4	2/10/2025	6,309	0.1%	26,510	12/31/2024
2024 Q3	11/14/2024	4,539	0.1%	16,510	9/30/2024
2024 Q2	11/26/2024	7,042	0.1%	28,510	6/30/2024
2024 Q1	11/26/2024	4,402	0.1%	28,510	3/31/2024
2023 Q4	11/26/2024	5,580	0.1%	28,510	12/31/2023
2023 Q3	11/26/2024	4,962	0.1%	28,510	9/30/2023
2023 Q2	11/26/2024	5,447	0.1%	28,510	6/30/2023
2023 Q1	11/26/2024	5,563	0.1%	28,510	3/31/2023
2022 Q4	11/26/2024	6,787	0.1%	28,510	12/31/2022
2022 Q3	11/26/2024	6,476	0.1%	30,930	9/30/2022
2022 Q2	11/26/2024	5,225	0.1%	35,930	6/30/2022
2022 Q1	11/25/2024	5,937	0.1%	35,930	3/31/2022
2021 Q4	11/25/2024	6,259	0.1%	36,800	12/31/2021
2021 Q3	11/25/2024	6,530	0.1%	36,800	9/30/2021
2021 Q2	11/25/2024	7,066	0.1%	42,600	6/30/2021
2021 Q1	11/25/2024	5,757	0.1%	42,600	3/31/2021
2020 Q4	11/25/2024	5,562	0.2%	42,600	12/31/2020
2020 Q3	11/25/2024	8,063	0.3%	55,600	9/30/2020
2020 Q2	11/22/2024	10,516	0.4%	71,100	6/30/2020
2020 Q1	11/22/2024	7,738	0.5%	71,100	3/31/2020
2019 Q4	11/22/2024	8,968	0.4%	76,300	12/31/2019
2019 Q3	11/22/2024	6,074	0.3%	74,900	9/30/2019
2019 Q2	11/22/2024	4,485	0.2%	63,100	6/30/2019
2019 Q1	11/22/2024	5,717	0.3%	63,100	3/31/2019
2018 Q4	11/26/2024	4,328	0.3%	63,100	12/31/2018